| Issue Type | Login |
|---|---|
| Country | France |
| Industry | Login |
| Region | Login |
| Maturity Date | 2029-03-21 |
| Par Value | 100000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 650.00 |
| Coupon | 0.875 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 650.000 |
| Min. Piece | Login |
| Min. Increment | Login |
This Sanofi corporate note has a 0.88% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 650.00 million EUR and matures on March 21, 2029 with a last coupon date of FEB 28, 2020. |
Sanofi, founded in 2004 and headquartered in Paris, France, is a global healthcare leader dedicated to improving health and well-being through innovative pharmaceuticals and vaccines. The company’s portfolio focuses on key therapeutic areas, including diabetes, oncology, immunology, and rare diseases, alongside a strong commitment to research and development.